Claudia-Skye (Skye) Xin Lee

Skye works with clients in:

• B&G Foods in its senior notes offering
• The underwriters in the IPO of Seaport Therapeutics, Inc.
• Warburg Pincus in its strategic investment in Global Eggs
• Angus Chemical Company in connection with financing matters
• The underwriters in Boots’ €650 million and £375 million senior secured notes offerings in connection with Sycamore Partners’ acquisition of Walgreens Boots Alliance
• Neuberger Berman in its preferred equity investment in Paradigm
• The financing sources supporting Walgreens Boots Alliance’s US$23.7 billion acquisition by Sycamore Partners
• The underwriters in the IPO of Via Transportation, Inc.
• Carlyle in its US$1.3 billion strategic investment in Trucordia
• Five Point in its US$450 million senior notes offering
• Figure Technology Solutions, Inc. in its US$787.5 million initial public offering
• The financing sources in Xerox Holdings Corporation's US$1.5 billion acquisition of Lexmark
• The underwriters in Mastercard's US$1.25 billion notes offering
• Vroom Inc. in its Chapter 11 bankruptcy proceedings
• Intrum AB in the ad hoc group of noteholders-led Chapter 11 restructuring
• Innophos Holdings, Inc. in liability management financing transactions
• The underwriters in Liquidia Corporation's follow-on public offering
• Afiniti, Ltd. in its Chapter 15 restructuring proceedings
• BMI Oldco Inc. in connection with post-confirmation matters
• The underwriters in the IPO of Karman Space and Defense
• MOD Super-Fast Pizza Holdings LLC in its Chapter 11 bankruptcy proceedings
• Sotera Health in its 2024 secured notes offering
• Endeavor Operating Company in connection with the sale of OpenBet
• Silver Lake in its take-private of Endeavor Operating Company
• PL Developments in its liability management transaction
• RR Donnelley & Sons Company in its consent solicitation and financing
• The underwriters in the IPO of MapLight Therapeutics
• Robertshaw in connection with restructuring and financing matters